SU 5416 semaxanib CAS NO.204005-46-9
- FOB Price: USD: /Metric Ton Get Latest Price
- Min.Order: 1 Gram
- Payment Terms: T/T
- Available Specifications:
Reagent Grade(1-10)Metric Ton
- Product Details
Keywords
- SU 5416
- semaxanib
- SU-5416
Quick Details
- ProName: SU 5416 semaxanib
- CasNo: 204005-46-9
- Molecular Formula: C15H14N2O
- Application: Use as research only
- DeliveryTime: on depending
- PackAge: 1g,5g,10g,100g,1000g,
- Port: Tianjin
- ProductionCapacity: Metric Ton/Day
- Purity: More than 98%
- Storage: Store at -20°C
- Transportation: by sea or by air
- LimitNum: 1 Gram
- Valid Period: 2 years
Superiority
Best quality & Attractive price & Professional service;
Kailiqi Biopharma is leading by professional teams for years and is qualified as the superior supplier of Merck, Novartis, Mitsui Chemicals.
Kailiqi Biopharma develop produce and distribute high quality pharmaceuticals, intermediates, special chemicals and OLED materials & OLED intermediates and other fine chemicals.
Kailiqi Biopharma also wants to be the STRATEGIC PARTNER for more and more pharma and chemical companies with our below Superiority:
1.Direct manufacturer and have several years experience in this aera.
2.Provide competitive price for every customer and guarantee the quality of our goods.
3.Specials are possible when client's order is big enough, including the discount policy;
4.Our company promise to deliver clients' package to his hands safely, or we'll cover the total loss and reship in time;
5. Our customers may buy our products again after they use our sample.
Our value:
1. Customer Satisfaction is our priority and guarantee for the future.
2. We co-develop products and projects with our partners.
3. We are passionate about the success of our projects.
Details
Semaxanib, also known as SU5416, is a quinolone derivative with potential antineoplastic activity. Semaxanib reversibly inhibits ATP binding to the tyrosine kinase domain of vascular endothelial growth factor receptor 2 (VEGFR2), which may inhibit VEGF-stimulated endothelial cell migration and proliferation and reduce the tumor microvasculature. This agent also inhibits the phosphorylation of the stem cell factor receptor tyrosine kinase c-kit, often expressed in acute myelogenous leukemia cells.
Shipping Condition:
Kailiqi Biopharma is a professional manufacturer specialized in the production and distribution of active pharmaceutical ingredients and intermediates.. We develop produce and distribute high quality pharmaceuticals, intermediates, special chemicals and OLED materials & OLED intermediates and other fine chemicals. Kailiqi Biopharmaconsists a team of professional analytical department complete QC&QA under strict SOPs, experienced sale and after-sale service, efficient logistic support.
We are good at technology:
1.High pressure hydrogenation
2. Low temperature reactions (-90°C)
3. Chiral compounds by asymmetric synthesis (either chiral auxiliaries or catalysts)
4. Small molecule biologics (e.g. non-natural amino acids, fluorinated amino acids)
5. Green reactions (ionic liquids/fluorous chemistry)
We could give you:
1. Best quality in your requirement
2. Competitive price in China market
3. Mature Technical support
4. Professional logistic support
All we want is win-win business. Send us your inquiries, you will get it!